(ShareCast News) - AstraZeneca said its Zurampic drug, used to treat gout, had received approval from the US Food and Drug Adminstration.Zurampic, also known as Lesinurad, is used in combination with another type of drug that reduces production of uric acid in the body.Sean Bohen, Executive Vice President of Global Medicines Development and Chief Medical Officer, AstraZeneca, said: "With the FDA approval of ZURAMPIC, we are pleased to offer a new treatment option for the many patients who are suffering from the effects of gout and who are not reaching the recommended serum uric acid treatment targets with the current standard of care."